Trandolapril represents a potent, long-acting angiotensin-converting enzyme inhibitor available in precise 1mg, 2mg, and 4mg therapeutic strengths. As a prodrug hydrolyzed to its a...

Trandolapril represents a potent, long-acting angiotensin-converting enzyme inhibitor available in precise 1mg, 2mg, and 4mg therapeutic strengths. As a prodrug hydrolyzed to its active diacid form trandolaprilat within the body, this metabolite effectively inhibits ACE, the enzyme responsible for converting angiotensin I to potent vasoconstrictor angiotensin II. Through this mechanism, Trandolapril induces vasodilation, reduces blood pressure, and decreases cardiac workload. Our product is supplied as high-purity active pharmaceutical ingredient manufactured in facilities complying with international Good Manufacturing Practice standards, ensuring every batch meets rigorous specifications for identity, purity, and potency while maintaining consistent therapeutic performance across all dosage variations and production scales.

This essential cardiovascular medication sees extensive utilization across global healthcare sectors. Major pharmaceutical manufacturers incorporate our Trandolapril API into both branded and generic antihypertensive medications, while suppliers depend on our consistent quality for national and international public health system tenders. Large drug wholesalers and distributors rely on our supply chain to stock hospital pharmacies, retail chains, and clinical institutions worldwide. Primary applications focus on hypertension treatment and post-myocardial infarction survival improvement in patients with left ventricular dysfunction, establishing Trandolapril as a cornerstone in cardiology and internal medicine practices across diverse healthcare delivery models and treatment facilities.

For pharmaceutical partners, our Trandolapril delivers exceptional reliability and business value through a dependable supply chain with consistent quality ensuring formulations remain effective and compliant with international regulatory standards. Our manufacturing differentiators include comprehensive documentation with batch-specific Certificates of Analysis and full traceability, minimizing production delays while protecting product integrity and market reputation. By partnering with our manufacturing operations, you secure a trusted source for vital cardiovascular medicine, enabling confident market demand fulfillment and strengthened product portfolio development within the competitive pharmaceutical sector while maintaining therapeutic excellence and patient safety as paramount priorities.

Key Features:
- Available in three standard therapeutic strengths: 1mg, 2mg, and 4mg
- Manufactured as high-purity API compliant with major pharmacopeias including USP and EP
- Produced in GMP-certified facilities ensuring international quality standards
- Comprehensive regulatory documentation with batch-specific Certificates of Analysis
- Full traceability and consistent batch-to-batch quality assurance

Benefits:
- Multiple dosage strengths enable precise therapeutic dosing for different patient needs
- Pharmacopeial compliance ensures regulatory acceptance across international markets
- GMP manufacturing guarantees product safety, efficacy, and quality consistency
- Complete documentation streamlines regulatory submissions and quality verification
- Reliable supply chain minimizes production interruptions and maintains market supply